Today: 5 April 2026
Browse Category

Stock Market 9 October 2025 - 10 October 2025

New Era Energy & Digital (NUAI) Stock Skyrockets on AI Data Center Dreams – Key Updates & Outlook

New Era Energy & Digital (NUAI) Stock Skyrockets on AI Data Center Dreams – Key Updates & Outlook

New Era Energy & Digital (NASDAQ: NUAI) shares jumped nearly 90% on Oct. 9, 2025, after announcing progress on its 1GW AI data center project in West Texas. The company, rebranded from New Era Helium in August, faces a Nasdaq delisting hearing on Oct. 16 despite recent financial moves and a brief market cap surge above $75 million.
USA Rare Earth Stock Skyrockets on Rare Earth Boom and White House Buzz – What’s Driving USAR’s Record High?

USA Rare Earth (USAR) Stock Soars on Rare Earth Boom and White House Buzz – What Investors Need to Know

USA Rare Earth (NASDAQ: USAR) shares surged over 120% year-to-date, closing in the low-$30s on Oct. 9, 2025, after news of White House talks and a $100 million acquisition of UK-based Less Common Metals. The company, still pre-revenue, is developing a Texas rare earth mine and Oklahoma magnet plant. USAR reported a Q2 net loss of $142 million, with about $120 million cash mid-2025.
BULLISH BREAKOUT: Google’s $3B Backstop Rockets TeraWulf (WULF) Stock to Multi-Year High

BULLISH BREAKOUT: Google’s $3B Backstop Rockets TeraWulf (WULF) Stock to Multi-Year High

TeraWulf shares surged to a 3.5-year high near $13.39 after Google increased its stake to 14% and boosted financial support to $3.2B in August. The company is arranging a $3B debt raise for expansion, advised by Morgan Stanley. Q2 revenue rose 34% to $47.6M, but net loss widened to $18.37M. As of June 30, TeraWulf held about $90M in cash and crypto, with $500M in convertible debt.
Bitfarms Stock Explodes on Crypto & AI Boom – 148% YTD Rally

Bitfarms Stock Explodes on Crypto & AI Boom – 148% YTD Rally

Bitfarms shares closed near $4.00 on NASDAQ and C$5.65 on TSX, up 148% year-to-date and hitting a new 52-week high. Q2 2025 revenue reached $78 million, but the company posted a $29 million net loss. Bitfarms operates 13 largely hydro-powered data centers and is expanding into HPC/AI with a new U.S. site plan. Analysts rate the stock a “Moderate Buy,” though targets sit below current prices.
AtlasClear (ATCH) Stock Skyrockets 50% on $20M Financing – Fintech Underdog Poised to Soar?

AtlasClear (ATCH) Stock Skyrockets 50% on $20M Financing – Fintech Underdog Poised to Soar?

AtlasClear (ATCH) closed at $0.36 on Oct. 8, 2025, with a 52-week range of $0.14–$26.94 and short interest near 28%. The company announced a $20M financing on Oct. 9, led by Funicular Funds, after closing a $5M round in September. AtlasClear reported FY2025 revenues of about $10–11M and negative margins, following an 83% reduction in debt. It plans to acquire Commercial Bancorp of Wyoming.
9 October 2025
Shocking IRS Update: New 2026 Tax Brackets Slashed for Millions – Here’s How Much You’ll Save

Shocking IRS Update: New 2026 Tax Brackets Slashed for Millions – Here’s How Much You’ll Save

The IRS released 2026 tax brackets and deductions, raising the standard deduction to $32,200 for joint filers and $16,100 for singles. All income thresholds shift higher, with a single earner making $50,000 now taxed at 12% instead of 22%. Marginal rates remain at 10%–37%. The changes follow the “One Big Beautiful Bill” signed in July 2025, which made most 2017 tax cuts permanent.
9 October 2025
CIFR Stock Skyrockets 320% After Google-Backed AI Mining Deal – Bubble or Boom?

CIFR Stock Skyrockets 320% After Google-Backed AI Mining Deal – Bubble or Boom?

Cipher Mining shares closed at $17.60 on Oct. 8, up nearly 12% after announcing a $3 billion, Google-backed AI hosting deal at its new Barber Lake site. The company’s market cap stands near $6 billion, with the stock up over 320% year-to-date. Cipher remains unprofitable, reporting a Q2 net loss of $46 million on $44 million revenue. Former CFO Ed Farrell retired Oct. 14, replaced by Greg Mumford.
Akero Therapeutics (AKRO) Skyrockets on $5.2 B Novo Nordisk Buyout – Pipeline Breakthroughs & Expert Outlook

Akero Therapeutics (AKRO) Skyrockets on $5.2 B Novo Nordisk Buyout – Pipeline Breakthroughs & Expert Outlook

Akero shares jumped nearly 19% to $55 on October 9, 2025 after Novo Nordisk announced a $5.2 billion buyout at $54 per share plus a $6 contingent payment. Novo will pay $4.7 billion upfront and another $500 million if Akero’s lead drug, efruxifermin, wins FDA approval by 2031. The deal has board approval and is expected to close by late 2025, pending regulatory and shareholder clearance.
Turn Therapeutics (TTRX) Skyrockets After Nasdaq Debut – Biotech Breakthrough or Hype?

Turn Therapeutics (TTRX) Skyrockets After Nasdaq Debut – Biotech Breakthrough or Hype?

Turn Therapeutics shares surged to around $23 midday Oct. 9 after opening at $24.50, following a prior close of $7. Market cap jumped to over $500 million from under $100 million. The stock debuted on Nasdaq Oct. 8 via direct listing and has traded with extreme volatility, more than tripling in value amid speculative interest. No new FDA approvals were announced this week.
Intellia Therapeutics Stock Soars on Gene-Editing Breakthrough – Analysts Eye 70–100% Upside

Intellia Therapeutics Stock Soars on Gene-Editing Breakthrough – Analysts Eye 70–100% Upside

NTLA surged past $26 on Oct. 8, 2025, after positive Phase 1 data for its ATTR program showed sustained TTR protein knockdown and no new safety issues. Trading volume spiked to 17 million shares. Wall Street remains bullish, with most analysts rating NTLA a Buy and targets averaging $31.7. Intellia holds $630–707 million in cash and expects funding to last into 2027.
Uzbekistan’s Big Bet: Import Fair 2025 Sparks a ‘Made in Uzbekistan’ Boom

Uzbekistan’s Big Bet: Import Fair 2025 Sparks a ‘Made in Uzbekistan’ Boom

Uzbekistan launched its first international Import Fair in Tashkent, unveiling $8.5 billion in new investment projects to boost local manufacturing and reduce imports. At the same time, 66 Uzbek firms promoted exports at MSV-2025 in Brno. GDP rose 7.2% year-on-year in early 2025, with FDI reaching $11.9 billion in 2024. Major foreign companies, including Inditex, praised recent trade reforms.
9 October 2025
United Airlines Stock Skyrockets on Travel Boom: Is $130 Next for UAL?

United Airlines Stock Skyrockets on Travel Boom: Is $130 Next for UAL?

United Airlines shares closed at $98.09 on Oct 8, 2025, up 1.5%, and surged to $104 in early trading Oct 9. The stock rebounded from $94 lows last week, tracking sector gains after Delta’s strong Q3 results. United announced new European and Middle Eastern routes for summer 2026. The ongoing U.S. government shutdown has caused flight delays but has not yet disrupted airline operations.
9 October 2025
Bluejay Diagnostics (BJDX) Stock Skyrockets on Sepsis Test Hopes – What Investors Need to Know

Bluejay Diagnostics (BJDX) Stock Skyrockets on Sepsis Test Hopes – What Investors Need to Know

Bluejay Diagnostics shares soared over 142% to $4.53 on Oct. 9 after announcing an expanded manufacturing partnership with SanyoSeiko. Trading volume hit 40 million shares, far above the 154,000 average. The company, which has no product revenue and only $5.7 million in cash, recently cut its workforce by 90%. Symphony, its lead diagnostic product, is not yet FDA-cleared.
American Airlines (AAL) Stock Takes Off on Travel Demand – Will It Keep Climbing or Hit Turbulence?

American Airlines (AAL) Stock Takes Off on Travel Demand – Will It Keep Climbing or Hit Turbulence?

American Airlines shares traded near $12 on Oct. 9, 2025, down 34% year-to-date and 15% in the past month. The stock rose 3–4% after Delta’s strong Q3 results, but American still faces weak domestic demand, high debt, and rising labor costs. Analysts remain split, with price targets ranging from $8 to $17. The company will report Q3 earnings later this month.
9 October 2025
Serve Robotics (SERV) Stock Soars on DoorDash Deal – The Next Big Bet in AI Delivery?

Serve Robotics (SERV) Stock Soars on DoorDash Deal – The Next Big Bet in AI Delivery?

Serve Robotics announced a partnership with DoorDash on October 9, 2025, to deploy its autonomous delivery robots in Los Angeles. The news sent SERV shares up 15% in one day. The company, which went public in April 2024, operates about 400 robots and plans to expand to 2,000 by year-end. Serve’s market cap stands near $800 million, though annual revenue remains under $2 million.
Powell’s Next Move Could Make or Break 2025’s Record Stock Rally

Powell’s Next Move Could Make or Break 2025’s Record Stock Rally

The S&P 500 and Nasdaq closed at record highs on Oct. 8, with the S&P up 0.6% to 6,753.72 and the Nasdaq rising 1.1% to 23,043.38. Gold surged past $4,000/oz for the first time, peaking at $4,078 before retreating slightly. Tech stocks soared, led by AMD’s 24% jump after an OpenAI deal. The Fed signaled more rate cuts after its first 2025 reduction, though inflation concerns remain.

Stock Market Today

  • Berkshire Hathaway (BRK.B) Seen as Undervalued by 40% After Recent Price Drop
    April 5, 2026, 1:38 AM EDT. Berkshire Hathaway's (BRK.B) share price recently softened, declining 3.9% year to date and 4.3% over 30 days, despite gains exceeding 52% over three years. The stock trades near $477, while an Excess Returns valuation model estimates intrinsic value at approximately $798 per share, indicating a 40.2% undervaluation. The model uses return on equity (ROE) compared to cost of equity to assess how efficiently the company generates earnings above shareholder expectations. Berkshire holds a stable ROE of 12.21% and a book value per share above $498,000. This suggests Berkshire remains a quality investment with a strong track record, though recent short-term price moves contrast with its longer-term performance. Investors should consider the diversified financial holding's fundamentals and varied valuation methods before deciding.
Go toTop